Perrigo | PRGO - Equity Capital And Reserves



Perrigo reported $4.47B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
AbbVie USD 1.46B 1.86B Mar/2025
Abbott USD 50.83B 1.76B Jun/2025
Bayer EUR 30.5B 2.08B Jun/2025
Bristol-Myers Squibb USD 17.49B 100M Jun/2025
Corcept Therapeutics USD 635.79M 47.49M Jun/2025
Dr.Reddys Laboratories INR 353.76B 18.26B Jun/2025
Eli Lilly USD 18.27B 2.43B Jun/2025
J&J USD 78.11B 6.62B Mar/2025
Merck USD 49.06B 725M Jun/2025
Nestle CHF 28.83B 7.09B Jun/2025
Pacira USD 757.77M 40.77M Jun/2025
Perrigo USD 4.47B 108.3M Jun/2025
Pfizer USD 88.7B 1.64B Jun/2025
Prestige Brands USD 1.86B 20.58M Jun/2025
Reckitt Benckiser GBP 6.7B 1.39B Dec/2024
Sanofi 70.28B 3.8B Jun/2025
Supernus Pharmaceuticals USD 1.06B 33.2M Jun/2025
Teva Pharmaceutical Industries USD 6.83B 572M Jun/2025
Xeris Pharmaceuticals USD -19300000 10.32M Jun/2025
Zoetis USD 4.98B 322M Jun/2025